PHIO PHARMACEUTICALS CORP. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2022-11-23: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2022-11-16; Total offering amount $1,750.
- 2018-08-17: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-08-08; Total offering amount $15,261,000.
- 2017-08-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-08-08; Total offering amount $15,261,000.
- 2013-03-26: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2013-03-12; Total offering amount $23,628,750.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2022-11-23 | Rule 506(b) | Equity | 2022-11-16 | $1,750 | $1,750 | $0 | 1 |
| 2018-08-17 D/A | Rule 506(b) | Equity | 2017-08-08 | $15,261,000 | $1,937,904 | $13,323,096 | 1 |
| 2017-08-18 | Rule 506(b) | Equity | 2017-08-08 | $15,261,000 | $261,000 | $15,000,000 | 1 |
| 2013-03-26 | Rule 506 | Equity | 2013-03-12 | $23,628,750 | $23,628,750 | $0 | 35 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |